Biochemical Characterization of α‐Adrenergic Receptors in Human Brain and Changes in Alzheimer‐Type Dementia
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Abstract Using ligand binding techniques, we studied α‐adrenergic receptors in brains obtained at autopsy from seven histologically normal controls and seven patients with histopathologically verified Alzheimer‐type dementia (ATD). Binding of the α‐adrenergic antagonists [3 H]prazosin and [3 H]yohimbine to membranes of human brains exhibited characteristics compatible with α 1‐ and α 2‐adrenergic receptors, respectively. Binding of both ligands was saturable and reversible, with dissociation constants of 0.15 n M for [3 H]prazosin and 5.5 n M for [3 H]yohimbine. [3 H]Prazosin binding was highest in the hippocampus and frontal cortex and lowest in the caudate and putamen in the control brains. [3 H]Yohimbine binding was highest in the nucleus basalis of Meynert (NbM) and frontal cortex and lowest in the caudate and cerebellar hemisphere in the control brains. Compared with values for the controls, [3 H]prazosin binding sites were significantly reduced in number in the hippocampus and cerebellar hemisphere, and [3 H]yohimbine binding sites were significantly reduced in number in the NbM in the ATD brains. These results suggest that α 1 and α 2‐adrenergic receptors are present in the human brain and that there are significant changes in numbers of both receptors in selected regions in patients with ATD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
SELECTIVE LOSS OF CENTRAL CHOLINERGIC NEURONS IN ALZHEIMER'S DISEASE
DAVIES, P. (1976) · The Lancet · doi:10.1016/s0140-6736(76)91936-x · Cited by 3,565
Mesulam, M. ‐., Mufson, E. J., Levey, A. I., & Wainer, B. H. (1983) · Journal of Comparative Neurology · doi:10.1002/cne.902140206 · Cited by 1,962
Alzheimer disease: Evidence for selective loss of cholinergic neurons in the nucleus basalis
Whitehouse, P. J., Price, D. L., Clark, A. W., Coyle, J. T., & DeLong, M. R. (1981) · Annals of Neurology · doi:10.1002/ana.410100203 · Cited by 1,736
Jones, E. G., Burton, H., Saper, C. B., & Swanson, L. W. (1976) · Journal of Comparative Neurology · doi:10.1002/cne.901670402 · Cited by 420
Cited by
Arnsten, A., Cai, J., & Goldman-Rakic, P. (1988) · The Journal of Neuroscience · doi:10.1523/jneurosci.08-11-04287.1988 · Cited by 391
Law, A. (2001) · Brain Research Reviews · doi:10.1016/s0165-0173(00)00051-5 · Cited by 314
Neurotransmitter receptors and cognitive dysfunction in Alzheimer's disease and Parkinson's disease
Xu, Y., Yan, J., Zhou, P., Li, J., Gao, H., Xia, Y., & Wang, Q. (2012) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2012.02.002 · Cited by 301
Kitamura, Y., Shimohama, S., Kamoshima, W., Ota, T., Matsuoka, Y., Nomura, Y., Smith, M. A., Perry, G., Whitehouse, P. J., & Taniguchi, T. (1998) · Brain Research · doi:10.1016/s0006-8993(97)01202-x · Cited by 269
Self-citationNicotinic acetylcholine receptors in neurological and psychiatric diseases
Terry, A. V., Jones, K., & Bertrand, D. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.106764 · Cited by 90
Metadata
- Authors
- Shimohama, S., Taniguchi, T., Fujiwara, M., & Kameyama, M.
- Venue
- Journal of Neurochemistry
- Publisher
- Wiley
- Published
- 1986-10
- Volume
- 47
- Issue
- 4
- Pages
- 1294-1301
- ISSN
- 0022-3042 (ISSN-L)
- 1471-4159
- OpenAlex
- W2145580671
- Cited by
- 73
- References
- 4
- FWCI
- 2.77
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Biochemical Characterization of α‐Adrenergic Receptors in Human Brain and Changes in Alzheimer‐Type Dementia. https://app.cochat.ai/papers/10.1111/j.1471-4159.1986.tb00753.x
- The paper
- Shimohama, S., Taniguchi, T., Fujiwara, M., & Kameyama, M. (1986). Biochemical Characterization of α‐Adrenergic Receptors in Human Brain and Changes in Alzheimer‐Type Dementia. Journal of Neurochemistry. https://doi.org/10.1111/j.1471-4159.1986.tb00753.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.